Tags

Type your tag names separated by a space and hit enter

Health-related quality of life during adjuvant treatment for breast cancer among postmenopausal women.
Eur J Oncol Nurs. 2008 Jul; 12(3):180-9.EJ

Abstract

The purpose of the present study was twofold: first, to describe changes of Health-Related Quality of Life (HRQoL) during the adjuvant treatment among postmenopausal women with breast cancer; second, in the same population to identify the best predictors of Overall Quality of Life (QoL) after treatment, from perceived functioning, symptoms, emotional distress and clinical/demographic variables measured at baseline. The study group was 150 women (> or = 55 years of age) scheduled for adjuvant chemotherapy (CT, n=75) or radiotherapy (RT, n=75). They were examined before (baseline), during and after completing the treatment. Data about QoL, perceived functioning, symptoms and emotional distress were collected with the European Organisation for Research and Treatment of Cancer (EORTC)-QLQ-C30, BR23 and Hospital Anxiety and Depression Scale (HADS) questionnaires. The general finding was that the adjuvant treatments were associated with decrease in overall QoL, physical and role functioning, anxiety and body image, as well as with increase in fatigue, dyspnoea, pain, nausea/vomiting, constipation and systemic therapy side effects measured over time. For women receiving CT, better emotional functioning and less pain at baseline predicted better overall QoL at the end of the treatment. For women receiving RT, better physical and emotional functioning, less breast symptoms and lower tumour stage at baseline predicted better overall QoL at the end of the treatment.

Authors+Show Affiliations

The Sahlgrenska Academy at Göteborg University, Institute of Health and Care Sciences, Göteborg, Sweden. maria.browall@vgregion.seNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

18343197

Citation

Browall, Maria, et al. "Health-related Quality of Life During Adjuvant Treatment for Breast Cancer Among Postmenopausal Women." European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society, vol. 12, no. 3, 2008, pp. 180-9.
Browall M, Ahlberg K, Karlsson P, et al. Health-related quality of life during adjuvant treatment for breast cancer among postmenopausal women. Eur J Oncol Nurs. 2008;12(3):180-9.
Browall, M., Ahlberg, K., Karlsson, P., Danielson, E., Persson, L. O., & Gaston-Johansson, F. (2008). Health-related quality of life during adjuvant treatment for breast cancer among postmenopausal women. European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society, 12(3), 180-9. https://doi.org/10.1016/j.ejon.2008.01.005
Browall M, et al. Health-related Quality of Life During Adjuvant Treatment for Breast Cancer Among Postmenopausal Women. Eur J Oncol Nurs. 2008;12(3):180-9. PubMed PMID: 18343197.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Health-related quality of life during adjuvant treatment for breast cancer among postmenopausal women. AU - Browall,Maria, AU - Ahlberg,Karin, AU - Karlsson,Per, AU - Danielson,Ella, AU - Persson,Lars-Olof, AU - Gaston-Johansson,Fannie, Y1 - 2008/03/14/ PY - 2007/10/30/received PY - 2008/01/06/revised PY - 2008/01/15/accepted PY - 2008/3/18/pubmed PY - 2008/10/25/medline PY - 2008/3/18/entrez SP - 180 EP - 9 JF - European journal of oncology nursing : the official journal of European Oncology Nursing Society JO - Eur J Oncol Nurs VL - 12 IS - 3 N2 - The purpose of the present study was twofold: first, to describe changes of Health-Related Quality of Life (HRQoL) during the adjuvant treatment among postmenopausal women with breast cancer; second, in the same population to identify the best predictors of Overall Quality of Life (QoL) after treatment, from perceived functioning, symptoms, emotional distress and clinical/demographic variables measured at baseline. The study group was 150 women (> or = 55 years of age) scheduled for adjuvant chemotherapy (CT, n=75) or radiotherapy (RT, n=75). They were examined before (baseline), during and after completing the treatment. Data about QoL, perceived functioning, symptoms and emotional distress were collected with the European Organisation for Research and Treatment of Cancer (EORTC)-QLQ-C30, BR23 and Hospital Anxiety and Depression Scale (HADS) questionnaires. The general finding was that the adjuvant treatments were associated with decrease in overall QoL, physical and role functioning, anxiety and body image, as well as with increase in fatigue, dyspnoea, pain, nausea/vomiting, constipation and systemic therapy side effects measured over time. For women receiving CT, better emotional functioning and less pain at baseline predicted better overall QoL at the end of the treatment. For women receiving RT, better physical and emotional functioning, less breast symptoms and lower tumour stage at baseline predicted better overall QoL at the end of the treatment. SN - 1462-3889 UR - https://www.unboundmedicine.com/medline/citation/18343197/Health_related_quality_of_life_during_adjuvant_treatment_for_breast_cancer_among_postmenopausal_women_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1462-3889(08)00021-5 DB - PRIME DP - Unbound Medicine ER -